544341 (5)
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE received clarifications from Emcure Pharmaceuticals Ltd and Landmark Global Learning Ltd regarding significant increase in volume/price … | |||||||||||||||
BSE received clarifications from Emcure Pharmaceuticals Ltd and Landmark Global Learning Ltd regarding significant increase in volume/price movement of their securities, both companies stating the movement is market-driven with no undisclosed material information.
| |||||||||||||||
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed … | |||||||||||||||
Emcure Pharmaceuticals and Landmark Global Learning submitted clarifications to BSE Surveillance Department stating no undisclosed price-sensitive information exists behind recent significant volume/price movements in their scrips.
| |||||||||||||||
BSE announces securities being added to, moved within, and removed from the Short Term 5/15/30 Days ASM Framework effective March 10, 2026. … | |||||||||||||||
BSE announces securities being added to, moved within, and removed from the Short Term 5/15/30 Days ASM Framework effective March 10, 2026. Five securities are newly shortlisted, one is moved to a higher stage, and four are moving out of the ST-ASM framework.
| |||||||||||||||
BSE revises price bands for 14 scrips across equity segment effective March 06, 2026, with bands set to 5%, 10%, or 20% for the listed … | |||||||||||||||
BSE revises price bands for 14 scrips across equity segment effective March 06, 2026, with bands set to 5%, 10%, or 20% for the listed securities.
| |||||||||||||||
BSE revises price bands for 14 scrips effective March 06, 2026, with most securities moved to 5% band and a few to 10% or 20% bands under … | |||||||||||||||
BSE revises price bands for 14 scrips effective March 06, 2026, with most securities moved to 5% band and a few to 10% or 20% bands under surveillance measures.
| |||||||||||||||